Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-22-031889
Filing Date
2022-11-14
Accepted
2022-11-14 14:41:50
Documents
40
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 471014
2 ex31-1.htm EX-31.1 16616
3 ex31-2.htm EX-31.2 16610
4 ex32-1.htm EX-32.1 7661
5 forn10-q_001.jpg GRAPHIC 3588
  Complete submission text file 0001493152-22-031889.txt   2175561

Data Files

Seq Description Document Type Size
6 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vapa-20220930.xsd EX-101.SCH 17816
7 INLINE XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vapa-20220930_cal.xml EX-101.CAL 31538
8 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vapa-20220930_def.xml EX-101.DEF 51057
9 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vapa-20220930_lab.xml EX-101.LAB 173929
10 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vapa-20220930_pre.xml EX-101.PRE 123192
34 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 199410
Mailing Address 5550 NICOLLET AVENUE MINNEAPOLIS MN 55419
Business Address 5550 NICOLLET AVENUE MINNEAPOLIS MN 55419 612-812-2037
CQENS Technologies Inc. (Filer) CIK: 0001479915 (see all company filings)

EIN.: 271521364 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55470 | Film No.: 221383921
SIC: 2834 Pharmaceutical Preparations